References
- Aydemir Ö, Güvenir T, Küey L. 1997. Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale. Turkish Journal of Psychiatry 8:280–287.
- Bhatia SC, Bhatia SK. 2002. Diagnosis and treatment of premenstrual dysphoric disorder. American Family Physician 66:1239–1248.
- Case AM, Reid RL. 2001. Menstrual cycle effects on common medical conditions. Comprehensive Therapy 27:65–71.
- Chisholm G, Jung SO, Cumming CE, Fox EE, Cumming DC. 1990. Premenstrual anxiety and depression: comparison of objective psychological tests with a retrospective questionnaire. Acta Psychiatrica Scandinavica 81:52–57.
- Critchlow DG, Bond AJ, Wingrove J. 2001. Mood disorder history and personality assessment in premenstrual dysphoric disorder. Journal of Clinical Psychiatry 62:688–693.
- Cumming CE, Fox EE, Cumming DC. 1995. Intermenstrual affect in women with symptomatic premenstrual change. Journal of Psychosomatic Research 39:261–269.
- Cunningham J, Yonkers KA, O’Brien S, Eriksson E. 2009. Update on research and treatment of premenstrual dysphoric disorder. Harvard Review of Psychiatry 17:120–137.
- Dewa CS, Lin E. 2000. Chronic physical illness, psychiatric disorder and disability in the workplace. Social Science and Medicine 51:41–50.
- De Ronchi D, Muro A, Marziani A, Rucci P. 2000. Personality disorders and depressive symptoms in late luteal phase dysphoric disorder. Psychotherapy and Psychosomatics 69:27–34.
- Delara M, Ghofranipour F, Azadfallah P, Tavafian SS, Kazemnejad A, Montazeri A. 2012. Health-related quality of life among adolescents with premenstrual disorders: a cross sectional study. Health Quality Life Outcomes 10:1–5.
- Dennerstein L, Lehert P, Bäckström TC, Heinemann K. 2010. The effect of premenstrual symptoms on activities of daily life. Fertility and Sterility 94:1059–1064.
- Derman O, Kanbur NO, Tokur TE, Kutluk T. 2004. Premenstrual syndrome and associated symptoms in adolescent girls. European Journal of Obstetrics, Gynecology, and Reproductive Biology 116:201–206.
- DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. Paris: Masson; 1996.
- Gold JH, Severino SK, editors. Premenstrual dysphorias: myths and realities. Washington: American Psychiatric Press; 3–17.
- Halbreich U, Borenstein J, Pearlstein T, Kahn LS. 2003. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology; 28:1–23.
- Hamaideh SH, Al-Ashram SA, Al-Modallal H. 2014. Premenstrual syndrome and premenstrual dysphoric disorder among Jordanian women. Journal of Psychiatric and Mental Health Nursing 21:60–68.
- Heinemann LAJ, Minh TD, Filonenko A, Uhl-Hochgrber K. 2010. Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of Life. Patient Centered Outcomes Research 3:125–132.
- Kocyigit H, Aydemir O, Olmez N, Memis A. 1999. Reliability and validity of the Turkish version of short form-36 (SF-36): a study in a group of patients with rheumatic diseases. The Turkish Journal of Drugs and Therapeutics 12:102–106.
- Kaplan Đ. 1995. Mental Disorders and Disability in a Primary Health Care Clinic in Semi Rural Area. Türk Psikiyatri Dergisi 6:169–179.
- Kashiwagi T, McClure JM Jr, Wetzel RO. 1976. Premenstrual affective syndrome and psychiatric disorder. Diseases of the Nervous System 37: 116–119.
- Kim DR, Gyulai L, Freeman EW, Morrison MF, Baldassano C, Dube B. 2004. Premenstrual dysphoric disorder and psychiatric co-morbidity. Archives of Women's Mental Health 7:37–47.
- Kitamura M, Takeda T, Koga S, Nagase S, Yaegashi N. 2012. Relationship between premenstrual symptoms and dysmenorrhea in Japanese high school students. Archives of Women's Mental Health 15:131–133.
- Logue CM, Moos RH. 1986. Perimenstrual symptoms: prevalence and risk factors. Psychosomatic Medicine 48:388–414.
- Obeidat BA, Alchalabi HA, Abdul-Razzak KK, Al-Farras MI. 2012. Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels. International Journal of Environmental Research and Public Health 9:4210–4222.
- Pearlstein T, Steiner M. 2008. Premenstrual dysphoric disorder: burden of illness and treatment update. Journal of Psychiatry Neuroscience 33:291–301.
- Rapkin AJ, Akopians AL. 2012. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause International 18:52–59.
- Rapkin AJ, Winer SA. 2009. Premenstrual syndrome and premenstrual dysphoric disorder: quality of Life and burden of illness. Expert Review of Pharmacoeconomics & Outcomes Research; 9: 157–170.
- Rapkin AJ, Mikacich JA. 2013. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents: diagnosis and pharmacological treatment. Paediatric Drugs 15:191–202.
- Rubinow DR, Schmidt PJ. 2006. Gonadal steroid regulation of mood: the lessons of premenstrual syndrome. Front in Neuroendocrinology 27: 210–216.
- Studd J. 2011. A guide to the treatment of depression in women by estrogens. Climacteric 14:637–642.
- Steiner M, Peer M, Palova E, Freeman EW, Macdougall M, Soares CN. 2011. The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Archives of Women's Mental Health 14:77–81.
- Treloar SA, Heath AC, Martin NG. 2002. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychology in Medical 32:25–38.
- Ulusoy M, Şahin NH, Erkmen H. 1998. Turkish version of the beck anxiety inventory: psychometric properties. Journal of Cognitive Psychotherapy: An International Quarterly 12:21–28.
- Wittchen HU, Becker E, Lieb R, Krause P. 2002. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine 32:119–132.
- Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S. 2008. Burden of premenstrual dysphoric disorder on health-related quality of life. Journal of Women's Health 17:113–121.
- Young EA, Korszun A. 2002. The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinology and Metabolism Clinics of North America 31:63–78.